Are health technology assessments of pharmacogenetic tests feasible? A case study of CYP2D6 testing in the treatment of breast cancer with tamoxifen

Author: Fleeman Nigel   Payne Katherine   Newman William G   Howell Sacha J   Boland Angela   Oyee James   Saborido Carlos Martin   Santander Ana Fernández   Dickson Rumona  

Publisher: Future Medicine

ISSN: 1741-0541

Source: Personalized Medicine, Vol.10, Iss.6, 2013-08, pp. : 601-611

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract